# Piedmont Realty Trust, Inc.: financial statements, quarterly

PDM · NYSE · CIK 1042776 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/pdm.md) · [Financials](/companies/pdm/financials.md) · [Filings](/companies/pdm/filings.md) · [Insiders](/companies/pdm/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/pdm/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [145 d](/filings/0001042776-26-000012.md) | [145](/filings/0001042776-25-000074.md) | [143](/filings/0001042776-25-000137.md) | [139](/filings/0001042776-25-000157.md) | [143 d](/filings/0001042776-26-000012.md) | [143](/filings/0001042776-26-000042.md) | [140](/filings/0001042776-26-000063.md) | [139](/filings/0001042776-26-000071.md) | [143 d](/filings/0001042776-26-000012.md) | [143](/filings/0001042776-26-000042.md) | [144](/filings/0001042776-26-000063.md) | [151](/filings/0001042776-26-000071.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [28.4 d](/filings/0001042776-24-000033.md) | [29.7](/filings/0001042776-24-000067.md) | [29.6](/filings/0001042776-25-000137.md) | [32.1](/filings/0001042776-25-000157.md) | [31.6 d](/filings/0001042776-26-000012.md) | [31.7](/filings/0001042776-26-000042.md) | [32.0](/filings/0001042776-26-000063.md) | [32.0](/filings/0001042776-26-000071.md) | [32.4 d](/filings/0001042776-26-000012.md) | [31.9](/filings/0001042776-26-000042.md) | [31.9](/filings/0001042776-26-000063.md) | [32.0](/filings/0001042776-26-000071.md) |
| Net income | $m | [(28.0) d](/filings/0001042776-26-000012.md) | [(27.8)](/filings/0001042776-25-000074.md) | [(9.8)](/filings/0001042776-25-000137.md) | [(11.5)](/filings/0001042776-25-000157.md) | [(30.0) d](/filings/0001042776-26-000012.md) | [(10.1)](/filings/0001042776-26-000042.md) | [(16.8)](/filings/0001042776-26-000063.md) | [(13.5)](/filings/0001042776-26-000071.md) | [(43.2) d](/filings/0001042776-26-000012.md) | [(12.9)](/filings/0001042776-26-000042.md) | [(11.1)](/filings/0001042776-26-000063.md) | [(21.0)](/filings/0001042776-26-000071.md) |
| Diluted EPS | $ per share | not reported | [(0.22)](/filings/0001042776-25-000074.md) | [(0.08)](/filings/0001042776-25-000137.md) | [(0.09)](/filings/0001042776-25-000157.md) | not reported | [(0.08)](/filings/0001042776-26-000042.md) | [(0.14)](/filings/0001042776-26-000063.md) | [(0.11)](/filings/0001042776-26-000071.md) | not reported | [(0.10)](/filings/0001042776-26-000042.md) | [(0.09)](/filings/0001042776-26-000063.md) | [(0.17)](/filings/0001042776-26-000071.md) |
| Basic EPS | $ per share | not reported | [(0.22)](/filings/0001042776-25-000074.md) | [(0.08)](/filings/0001042776-25-000137.md) | [(0.09)](/filings/0001042776-25-000157.md) | not reported | [(0.08)](/filings/0001042776-26-000042.md) | [(0.14)](/filings/0001042776-26-000063.md) | [(0.11)](/filings/0001042776-26-000071.md) | not reported | [(0.10)](/filings/0001042776-26-000042.md) | [(0.09)](/filings/0001042776-26-000063.md) | [(0.17)](/filings/0001042776-26-000071.md) |

- Revenue: us-gaap:Revenues
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.8](/filings/0001042776-26-000012.md) | [3.5](/filings/0001042776-25-000074.md) | [138](/filings/0001042776-25-000137.md) | [134](/filings/0001042776-25-000157.md) | [110](/filings/0001042776-26-000071.md) | [2.9](/filings/0001042776-26-000042.md) | [3.3](/filings/0001042776-26-000063.md) | [3.0](/filings/0001042776-26-000071.md) | [0.7](/filings/0001042776-26-000071.md) | [2.3](/filings/0001042776-26-000042.md) | [16.8](/filings/0001042776-26-000063.md) | [3.9](/filings/0001042776-26-000071.md) |
| Total assets | $m | [4,057](/filings/0001042776-25-000042.md) | [3,994](/filings/0001042776-24-000067.md) | [4,159](/filings/0001042776-24-000096.md) | [4,138](/filings/0001042776-24-000109.md) | [4,115](/filings/0001042776-26-000012.md) | [4,004](/filings/0001042776-25-000074.md) | [3,980](/filings/0001042776-25-000137.md) | [4,004](/filings/0001042776-25-000157.md) | [4,031](/filings/0001042776-26-000071.md) | [4,034](/filings/0001042776-26-000042.md) | [4,048](/filings/0001042776-26-000063.md) | [4,092](/filings/0001042776-26-000071.md) |
| Total liabilities | $m | [2,334](/filings/0001042776-25-000042.md) | [2,312](/filings/0001042776-24-000067.md) | [2,500](/filings/0001042776-24-000096.md) | [2,508](/filings/0001042776-24-000109.md) | [2,527](/filings/0001042776-26-000012.md) | [2,442](/filings/0001042776-25-000074.md) | [2,432](/filings/0001042776-25-000137.md) | [2,467](/filings/0001042776-25-000157.md) | [2,535](/filings/0001042776-26-000071.md) | [2,551](/filings/0001042776-26-000042.md) | [2,573](/filings/0001042776-26-000063.md) | [2,643](/filings/0001042776-26-000071.md) |
| Long-term debt | $m | [2,055](/filings/0001042776-25-000042.md) | [2,070](/filings/0001042776-24-000067.md) | [2,222](/filings/0001042776-24-000096.md) | [2,222](/filings/0001042776-24-000109.md) | [2,222](/filings/0001042776-26-000012.md) | [2,186](/filings/0001042776-25-000074.md) | [2,178](/filings/0001042776-25-000137.md) | [2,193](/filings/0001042776-25-000157.md) | [2,225](/filings/0001042776-26-000071.md) | [2,252](/filings/0001042776-26-000042.md) | [2,251](/filings/0001042776-26-000063.md) | [2,341](/filings/0001042776-26-000071.md) |
| Shareholders' equity | $m | [1,721](/filings/0001042776-25-000042.md) | [1,680](/filings/0001042776-24-000067.md) | [1,657](/filings/0001042776-24-000096.md) | [1,629](/filings/0001042776-24-000109.md) | [1,587](/filings/0001042776-26-000012.md) | [1,560](/filings/0001042776-25-000074.md) | [1,546](/filings/0001042776-25-000137.md) | [1,536](/filings/0001042776-25-000157.md) | [1,495](/filings/0001042776-26-000071.md) | [1,481](/filings/0001042776-26-000042.md) | [1,473](/filings/0001042776-26-000063.md) | [1,447](/filings/0001042776-26-000071.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [49.6 d](/filings/0001042776-26-000012.md) | [23.4](/filings/0001042776-25-000074.md) | [66.8 d](/filings/0001042776-25-000137.md) | [42.9 d](/filings/0001042776-25-000157.md) | [65.0 d](/filings/0001042776-26-000012.md) | [3.7](/filings/0001042776-26-000042.md) | [50.1 d](/filings/0001042776-26-000063.md) | [35.8 d](/filings/0001042776-26-000071.md) | [50.9 d](/filings/0001042776-26-000012.md) | [28.1](/filings/0001042776-26-000042.md) | [64.3 d](/filings/0001042776-26-000063.md) | [24.4 d](/filings/0001042776-26-000071.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Dividends paid | $m | [0.3 d](/filings/0001042776-26-000012.md) | [30.6](/filings/0001042776-25-000074.md) | [15.5 d](/filings/0001042776-25-000137.md) | [15.5 d](/filings/0001042776-25-000157.md) | [0.2 d](/filings/0001042776-26-000012.md) | [30.8](/filings/0001042776-26-000042.md) | [0.0 d](/filings/0001042776-26-000063.md) | [0.0 d](/filings/0001042776-26-000071.md) | [0.0 d](/filings/0001042776-26-000012.md) | [0.1](/filings/0001042776-26-000042.md) | [0.0 d](/filings/0001042776-26-000063.md) | [0.0 d](/filings/0001042776-26-000071.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: not reported

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [124](/filings/0001042776-24-000067.md) | [124](/filings/0001042776-24-000096.md) | [124](/filings/0001042776-24-000109.md) | [124](/filings/0001042776-25-000074.md) | [124](/filings/0001042776-25-000137.md) | [124](/filings/0001042776-25-000157.md) | [124](/filings/0001042776-26-000042.md) | [124](/filings/0001042776-26-000063.md) | [125](/filings/0001042776-26-000071.md) | [125](/filings/0001042776-26-000042.md) | [125](/filings/0001042776-26-000063.md) | [125](/filings/0001042776-26-000071.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 123,824,675 at 2026-10-23, from the cover of the [10-Q filed 2026-10-26](/filings/0001042776-26-000071.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 26, 2026, 16:39 ET. No prices; not investment advice.